| __timestamp | Amphastar Pharmaceuticals, Inc. | Bausch Health Companies Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 246000000 |
| Thursday, January 1, 2015 | 37065000 | 582800000 |
| Friday, January 1, 2016 | 41199000 | 455000000 |
| Sunday, January 1, 2017 | 43415000 | 366000000 |
| Monday, January 1, 2018 | 57564000 | 414000000 |
| Tuesday, January 1, 2019 | 68853000 | 471000000 |
| Wednesday, January 1, 2020 | 67229000 | 452000000 |
| Friday, January 1, 2021 | 60932000 | 465000000 |
| Saturday, January 1, 2022 | 74771000 | 529000000 |
| Sunday, January 1, 2023 | 73741000 | 604000000 |
Data in motion
In the ever-evolving pharmaceutical industry, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Bausch Health consistently allocated a significant portion of its resources to R&D, with expenditures peaking at approximately 604% higher than Amphastar's in 2023. This trend underscores Bausch Health's strategic focus on innovation, despite fluctuations in annual spending. Meanwhile, Amphastar has shown a steady increase in its R&D budget, growing by over 160% from 2014 to 2023. This growth reflects Amphastar's gradual yet determined push towards enhancing its research capabilities. As the pharmaceutical landscape continues to shift, these spending patterns offer valuable insights into each company's long-term vision and priorities.
Pfizer Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Viatris Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Ultragenyx Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Bausch Health Companies Inc.
R&D Spending Showdown: Veracyte, Inc. vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Xenon Pharmaceuticals Inc. vs Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Mesoblast Limited
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Wave Life Sciences Ltd. and Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Amphastar Pharmaceuticals, Inc. vs Novavax, Inc.